Form 4 for GH Guardant Health, Inc.
Accepted 2026-08-12 18:20:38 ET · period of report 2026-08-10 · accession 0001753159-26-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-08-12 18:20 | 2026-08-10 | GH | Talasaz AmirAli | Co-CEO, Dir | G - Gift | $0.00 | 0 | 75.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-10 | G | D | 75,000 | $0.00 | 1,824,351 | I Shares held by Talasaz and Eskandari 2017 Family Trust | — | — | (F1) Reflects changes in form of ownership from Talasaz and Eskandari 2017 Family Trust due to the gift of shares to The Talasaz Family Foundation. |
| 2 | Common | Common Stock | 2026-08-10 | G | A | 75,000 | $0.00 | 75,000 | I Shares held by the Talasaz Family Foundation | — | — | (F1) Reflects changes in form of ownership from Talasaz and Eskandari 2017 Family Trust due to the gift of shares to The Talasaz Family Foundation. |